share_log

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10

Craig-Hallum維持對ironwood醫藥的買入評級,將目標價下調至10美元。
Benzinga ·  08/09 12:17  · 評級/大行評級

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price target from $14 to $10.

Craig-Hallum分析師Chase Knickerbocker推薦買入ironwood醫藥(納斯達克代碼:IRWD),並將目標股價從14美元下調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論